Stay updated on Ganaxolone in PCDH19 Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Ganaxolone in PCDH19 Epilepsy Clinical Trial page.

Latest updates to the Ganaxolone in PCDH19 Epilepsy Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision indicates the platform was updated from v3.6.5 to v3.6.6, a minor version bump. This update does not alter study data, eligibility criteria, or other core content on the page.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page shows a new revision label, updating from v3.6.4 to v3.6.5, indicating a new build/deployment. No visible content or functionality changes were made.SummaryDifference0.1%

- Check53 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, indicating a minor version bump with no visible changes to the study details.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, signaling a minor backend/content-management update.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page now displays a new revision tag (v3.6.2) replacing the previous v3.6.0, signaling a more recent deployment of the page.SummaryDifference0.1%

- Check96 days agoChange DetectedRecruitment status is updated to 'No longer looking for participants', signaling enrollment has ended. The treatment section header is reformatted to 'Intervention/Treatment', new help pages are added ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'), and a new page revision label is introduced ('Revision: v3.6.0').SummaryDifference0.4%

Stay in the know with updates to Ganaxolone in PCDH19 Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ganaxolone in PCDH19 Epilepsy Clinical Trial page.